Interrogating our previously published functional recovery data (27) for WT mice that received 3 weeks of daily intranasal treatment with C3a or PBS, we calculated the correlation between GFAP expression in peri-infarct cortex at 8 weeks (P56) after stroke and the improvement in motor performance between P7 and P56. The gene discussed is GFAP; the disease is Stroke.